Therapeutic potential of combination antimicrobial drug amoxycillin/clavulanate in children

Combination of amoxicillin/clavulanate firstly occurred on a pharmacological market in 1977 and it is still has been used successfully for treatment of infections in children and adults. Clavulanic acid provides an opportunity to fight microorganisms that produce specific enzymes – beta-lactamases. Despite the global antibiotic resistance problem, amoxicillin/clavulanate is still active against different infections in children. The level of susceptibility to amoxicillin/clavulanate of St. pneumonia is high for a period of 40 years. Based on the multicenter study of the antimicrobial resistance of pneumococci, haemophilus, group A streptococci, moraxella PeGAS I-III findings, susceptibility to amoxicillin/clavulanate of St. Pneumoniae in Russian Federation has been changed slightly from 100% to 99.6% over a period of 1993 – 2009 y. The systematic review with meta-analysis published in 2019 showed that the sensitivity of hemophilic bacillus and moraxella to amoxicillin/clavulanate in the treatment of acute otitis media accounted for 98% each. The article presents data on clavulanic acid action mechanism, spectrum of amoxicillin/clavulanate activity on the ground of clinical trials and meta-analyses, priority of suspension usage in pediatric practice is explained. Possibilities of using in pediatric practice were also viewed.

[1]  M. Edelstein,et al.  [Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia, Belarus and Kazakhstan: results of the international multicenter study Darmis-2018]. , 2020, Urologiia.

[2]  M. P. van der Linden,et al.  Co-carriage of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among three different age categories of children in Hungary , 2020, PloS one.

[3]  Александр Игоревич Синопальников,et al.  ВНЕБОЛЬНИЧНАЯ ПНЕВМОНИЯ У ГОСПИТАЛИЗИРОВАННЫХ БОЛЬНЫХ: КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ , 2019 .

[4]  L. Pignataro,et al.  Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Treatment. , 2019, The Pediatric infectious disease journal.

[5]  M. Drinnan,et al.  A systematic review and meta-analysis of antimicrobial resistance in paediatric acute otitis media. , 2019, International journal of pediatric otorhinolaryngology.

[6]  A. Leung,et al.  Urinary Tract Infection in Children , 2019, Recent patents on inflammation & allergy drug discovery.

[7]  I. Morrissey,et al.  Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia , 2018, The Journal of antimicrobial chemotherapy.

[8]  Козлов Роман Сергеевич,et al.  Резолюция Экспертного совета "принципы рациональной антибиотикотерапии респираторных инфекций у детей. Сохраним антибиотики для будущих поколений" 31 марта 2018 г. , Москва , 2018 .

[9]  Синопальников Александр Игоревич.  Внебольничные инфекции нижних дыхательных путей: подходы к рациональной антибактериальной терапии , 2017 .

[10]  L. Shortliffe.  Reaffirmation of AAP Clinical Practice Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children 2–24 Months of Age , 2016, Pediatrics.

[11]  S. Marcella,et al.  In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study , 2016, Infectious Diseases and Therapy.

[12]  PHARMACOPOEIA MONOGRAPH,et al.  MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION , 2016 .

[13]  R. Bonomo,et al.  Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase. , 2015, ACS infectious diseases.

[14]  A. Vick.  Antibiotics for lower urinary tract infection in children. , 2014, Nursing times.

[15]  Садыкова Юлия Жавитовна.  Современное состояние системы здравоохранения Российской Федерации , 2014 .

[16]  T. Kurosaki,et al.  Comparison of clinical efficacy between 3-day combined clavulanate/amoxicillin preparation treatment and 10-day amoxicillin treatment in children with pharyngolaryngitis or tonsillitis , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[17]  D. Livermore,et al.  Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes. , 2013, The Journal of antimicrobial chemotherapy.

[18]  D. Ollis,et al.  The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening. , 2011, Bioorganic & medicinal chemistry letters.

[19]  Роман Сергеевич Козлов,et al.  Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999-2009 гг. (результаты многоцентрового проспективного исследования ПеГАС) , 2010 .

[20]  G. Eliopoulos,et al.  The Sanford guide to antimicrobial therapy , 2010 .

[21]  M. Laopaiboon,et al.  Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. , 2008, The Cochrane database of systematic reviews.

[22]  H. Palyutin.  Antimicrobial Resistance of Streptococcus pyogenes in Russia: Results of Multicentre Prospective Study PeHASI , 2005 .

[23]  J. Larcombe,et al.  Urinary Tract Infection in Children , 2018, Current Pediatrics Reports.

[24]  M. Jacobs,et al.  The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. , 2003, The Journal of antimicrobial chemotherapy.

[25]  M. Cole.  Biochemistry and Action of Clavulanic Acid , 1982, Scottish medical journal.

[26]  R. Wise,et al.  In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin , 1978, Antimicrobial Agents and Chemotherapy.